Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

[The Implications of Primary Tumor Resection during Recent Chemotherapy of Unresectable Colon Cancer].

Ohnishi T, Fujie Y, Nonaka R, Nishida K, Tsukabe M, Hashimoto K, Fujita S, Fujita JY, Imaoka S, Yoshida T.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1524-6. Japanese.

PMID:
26805084
2.

Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study.

Karoui M, Roudot-Thoraval F, Mesli F, Mitry E, Aparicio T, Des Guetz G, Louvet C, Landi B, Tiret E, Sobhani I.

Dis Colon Rectum. 2011 Aug;54(8):930-8. doi: 10.1097/DCR.0b013e31821cced0. Erratum in: Dis Colon Rectum. 2011 Oct;54(10):1338. DesGuetz, Gaetan [corrected to Des Guetz, Gaetan].

PMID:
21730780
3.

Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.

Leone F, Artale S, Marino D, Cagnazzo C, Cascinu S, Pinto C, Fornarini G, Tampellini M, Di Fabio F, Sartore-Bianchi A, De Carlis L, Pugliese R, Capussotti L, Gioeni L, Siena S, Aglietta M.

Cancer. 2013 Oct 1;119(19):3429-35. doi: 10.1002/cncr.28223. Epub 2013 Jul 18.

4.

Bevacizumab-containing chemotherapy is safe in patients with unresectable metastatic colorectal cancer and a synchronous asymptomatic primary tumor.

Cetin B, Kaplan MA, Berk V, Tufan G, Benekli M, Isikdogan A, Ozkan M, Coskun U, Buyukberber S.

Jpn J Clin Oncol. 2013 Jan;43(1):28-32. doi: 10.1093/jjco/hys175. Epub 2012 Oct 28.

PMID:
23107836
5.

[A case of unresectable multiple hepatic metastases from ascending colon cancer successfully treated with panitumumab and FOLFIRI(5-FU/LV/irinotecan)therapy].

Yoshida R, Matsuura T, Hijikawa K, Yanagida H, Kitade H, Takada H, Kwon AH.

Gan To Kagaku Ryoho. 2012 Oct;39(10):1575-7. Japanese.

PMID:
23064076
6.

[A case of hepatic resection after chemotherapy for metastatic colon cancer of the liver with invasion of the inferior vena cava and hepatic vein].

Komatsu H, Tomokuni A, Wada H, Kobayashi S, Tomimaru Y, Asaoka T, Hama N, Kawamoto K, Marubashi S, Eguchi H, Umeshita K, Doki Y, Mori M, Nagano H.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2059-61. Japanese.

PMID:
25731422
7.

[A Case of Conversion Surgery for Unresectable Colorectal Liver Metastases, Following Effective Combined Chemotherapy with Molecular Targeting Agents].

Nakashima C, Suzuki N, Tomochika S, Tanaka H, Tokumitsu Y, Kanekiyo S, Tokuhisa Y, Iida M, Sakamoto K, Takeda S, Yamamoto S, Yoshino S, Hazama S, Ueno T, Nagano H.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1272-1274. Japanese.

PMID:
29394604
8.

[A case of descending colon cancer with multiple liver metastases effectively treated with capecitabine/oxaliplatin (CapeOX) and bevacizumab].

Nakano M, Kameyama H, Shimada Y, Hashimoto Y, Hosoi M, Nakano M, Nogami H, Hanyu T, Takizawa K, Ishikawa T, Sakata J, Kobayashi T, Minagawa M, Kosugi S, Koyama Y, Wakai T.

Gan To Kagaku Ryoho. 2014 Nov;41(12):1785-7. Japanese.

PMID:
25731329
9.

Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection.

You YN, Shiozaki H, Lee JE, Passot G, Goumard C, Okuno M, Aloia TA, Eng C, Chang G, Vauthey JN, Conrad C.

Ann Surg Oncol. 2017 Sep;24(9):2595. doi: 10.1245/s10434-017-5878-3. Epub 2017 May 16.

PMID:
28510798
10.

[A case of ascending colon cancer with unresectable distant metastases treated by systemic chemotherapy].

Sugimoto K, Tashiro Y, Nagayasu K, Niwa K, Ono S, Ishiyama S, Hata M, Komiyama H, Takahashi M, Yaginuma Y, Kojima Y, Goto M, Tanaka M, Sengoku H, Okuzawa A, Tomiki Y, Sakamoto K.

Gan To Kagaku Ryoho. 2010 Jun;37(6):1167-70. Japanese.

PMID:
20567130
11.
12.

Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.

D ľAngelica MI, Correa-Gallego C, Paty PB, Cercek A, Gewirtz AN, Chou JF, Capanu M, Kingham TP, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR, Kemeny N.

Ann Surg. 2015 Feb;261(2):353-60. doi: 10.1097/SLA.0000000000000614.

13.

Primary Tumor Resection Offers Higher Survival Advantage in KRAS Mutant Metastatic Colorectal Cancer Patients.

Kodaz H, Erdogan B, Hacibekiroglu I, Turkmen E, Tozkir H, Albayrak D, Uzunoglu S, Cicin I.

Hepatogastroenterology. 2015 Jun;62(140):876-9.

PMID:
26902020
14.

Does "conversion chemotherapy" really improve survival in metastatic colorectal cancer patients with liver-limited disease?

Kataoka K, Kanazawa A, Iwamoto S, Kato T, Nakajima A, Arimoto A.

World J Surg. 2014 Apr;38(4):936-46. doi: 10.1007/s00268-013-2305-1.

PMID:
24166026
15.

Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.

Ochiai T, Masuda T, Yagi M, Kasai R, Furuyama T, Tsukamoto K, Ito H, Igari K, Aihara A, Kumagai Y, Iida M, Odajima H, Tanaka S, Arii S, Yamazaki S.

Int Surg. 2012 Jan-Mar;97(1):6-13. doi: 10.9738/CC88.1.

16.

[Two Cases of Effective Hepatic Arterial Infusion Chemotherapy for Liver Metastases of Colon Cancer Resistant to Systemic Chemotherapy].

Date Y, Hisaka T, Takahashi K, Nakayama G, Akashi M, Kawahara R, Sakai H, Ishikawa H, Yasunaga M, Uchida S, Horiuchi H, Okuda K, Matsunaga M, Miwa K, Akagi Y.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1518-20. Japanese.

PMID:
26805082
17.

[A Case of Ascending Colon Cancer with Synchronous Liver Metastases and Peritoneal Dissemination].

Mito M, Kameyama H, Shimada Y, Yamada S, Hotta S, Hirose Y, Yagi R, Tajima Y, Nakano M, Okamura T, Nakano M, Ichikawa H, Nagahashi M, Sakata J, Wakai T.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1126-1128. Japanese.

PMID:
29394555
18.

Up-front systemic chemotherapy is a feasible option compared to primary tumor resection followed by chemotherapy for colorectal cancer with unresectable synchronous metastases.

Niitsu H, Hinoi T, Shimomura M, Egi H, Hattori M, Ishizaki Y, Adachi T, Saito Y, Miguchi M, Sawada H, Kochi M, Mukai S, Ohdan H.

World J Surg Oncol. 2015 Apr 24;13:162. doi: 10.1186/s12957-015-0570-1.

19.

Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.

McCahill LE, Yothers G, Sharif S, Petrelli NJ, Lai LL, Bechar N, Giguere JK, Dakhil SR, Fehrenbacher L, Lopa SH, Wagman LD, O'Connell MJ, Wolmark N.

J Clin Oncol. 2012 Sep 10;30(26):3223-8. doi: 10.1200/JCO.2012.42.4044. Epub 2012 Aug 6.

20.

[A Case of Hemodialysis Patients with Resected Synchronous Multiple Metastases from Colorectal Cancer Successfully Treated with CapeOX Therapy].

Yamagishi S, Suematsu Y, Takahashi M, Saito H, Nakayama M, Fukabori M, Morita A, Wakabayashi K, Itoh Y.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1767-1769. Japanese.

PMID:
28133125

Supplemental Content

Support Center